EPURIS ® : Now Publicly Reimbursed in Alberta as a General Benefit

Cipher is a proudly Canadian Company Dear Healthcare Professional, Cipher Pharmaceuticals Inc. is pleased to inform you that EPURIS ® (isotretinoin) capsules have been approved for funding by Alberta Health effective today October 1 st , 2026. EPURIS ® capsules are available in the following strengths: 10 mg, 20 mg, 30 mg and 40 mg and now has FULL FORMULARY LISTING in the ALBERTA DRUG BENEFIT LIST (ADBL) . EPURIS ® is indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobata and recalcitrant acne 1 . Initial Dosing and Maintenance: For more Information or to have a sales representative visit you, please contact Cipher Pharmaceuticals Inc. at 1-855-4EPURIS (1-855-437-8747) or email at [email protected] . For complete prescribing information and access to the PEER™ Program go to www.epuris.ca . Reference: 1. Cipher Pharmaceuticals Inc. Epuris™ Product Monograph. May 13, 2025

The release as fetched from its publisher. cipherpharma.com ↗